Power Law company profile

Hyperion Therapeutics

Biotech & Life Sciences · Dublin, Ireland · Founded 2006 · IPO 2012 Unicorn

Amgen Completes Acquisition of Horizon Therapeutics

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

5 investors on Hyperion Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage

Highland Capital Partners

NEA

Sofinnova Investments

Series B+ 2 investors entered at this stage

Panorama Capital

Bay City Capital

Global footprint

Where Hyperion Therapeutics has talent and traffic

Workforce by country

🇮🇪 Ireland · Dublin HQ

Book a demo for the full country breakdown

Patent intelligence

$20M patent portfolio · 3 active families

Estimated portfolio value

$20M

26.5× smaller than top peer ChemoCentryx ($524M)

3 active patent families

Where Hyperion Therapeutics innovates Hepatic encephalopathyEncephalopathyProdrugDosing regimenNitrogen

Where Hyperion Therapeutics concentrates vs peers

Each axis is a top-10 topic across Hyperion Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Hyperion Therapeutics

An AI-synthesized read of the highest-engagement posts about Hyperion Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hyperion Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles